Camber Capital Management’s Globus Medical GMED Stock Holding History

Camber Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$47.2M	Sell	800,000 -450,000	-36%	-$29.1M	4.43%	6
2025 Q1	$91.5M	Buy	1,250,000 +25,000	+2%	+$2.07M	3.25%	8
2024 Q4	$101M	Sell	1,225,000 -925,000	-43%	-$73M	2.34%	15
2024 Q3	$154M	Sell	2,150,000 -350,000	-14%	-$24.7M	4.89%	6
2024 Q2	$171M	Hold	2,500,000	–	–	4.74%	6
2024 Q1	$134M	Buy	2,500,000 +250,000	+11%	+$13.4M	3.29%	11
2023 Q4	$120M	Buy	2,250,000 +525,000	+30%	+$25.6M	3.06%	10
2023 Q3	$85.6M	Buy	1,725,000 +725,000	+73%	+$40.5M	2.82%	16
2023 Q2	$59.5M	Buy	1,000,000 +695,000	+228%	+$39.6M	1.94%	19
2023 Q1	$17.3M	Buy	+305,000	New	+$19.6M	0.53%	30

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Camber Capital Management's GMED Position: Q2 2025 in Review

Camber Capital Management reduced its Globus Medical (GMED) stake by 36% in Q2 2025, selling an estimated $29.1M and leaving 800,000 shares worth $47.2M. The position accounts for 4.43% of the portfolio, ranked #6.

Camber Capital Management first reported a position in GMED in Q1 2023 and has held it in 10 quarters since. The position peaked at $171M in Q2 2024. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

Camber Capital Management held 800,000 shares of Globus Medical worth $47.2M as of Q2 2025.
Camber Capital Management sold 450,000 Globus Medical shares in Q2 2025, an estimated $29.1M.
Globus Medical made up 4.43% of Camber Capital Management's portfolio in Q2 2025, its #6 holding.
Camber Capital Management first reported a position in Globus Medical in Q1 2023 and has held it in 10 quarters since.
Camber Capital Management's Globus Medical position peaked at $171M in Q2 2024.
480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Camber Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.